FDA Approves Sculptra Aesthetic, a Facial Injectable for Correction of Nasolabial Folds and Other Facial Wrinkles
July 29, 2009
BRIDGEWATER, N.J., July 29 /PRNewswire-FirstCall/ -- Sanofi-aventis
U.S. announced today that the U.S. Food and Drug Administration (FDA)
approved Sculptra Aesthetic (injectable poly-L-lactic acid) for the
correction of shallow to deep nasolabial fold (smile lines) contour
deficiencies and other facial wrinkles which are treated with the
appropriate injection technique in healthy patients.
BRIDGEWATER, N.J., July 29 /PRNewswire-FirstCall/ -- Sanofi-aventis
U.S. announced today that the U.S. Food and Drug Administration (FDA)
approved Sculptra Aesthetic (injectable poly-L-lactic acid) for the
correction of shallow to deep nasolabial fold (smile lines) contour
deficiencies and other facial wrinkles which are treated with the
appropriate injection technique in healthy patients.
Comentarios
Publicar un comentario